Correction: Cardiotoxicity following thoracic radiotherapy for lung cancer.
作者信息
Walls Gerard M, Bergom Carmen, Mitchell Joshua D, Rentschler Stacey L, Hugo Geoffrey D, Samson Pamela P, Robinson Clifford G
机构信息
Department of Radiation Oncology, Washington University in St Louis, Saint Louis, MO, USA.
Patrick Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, NI, USA.
出版信息
Br J Cancer. 2025 Mar;132(4):401-407. doi: 10.1038/s41416-024-02926-x.
Abstract
摘要
相似文献
1
Correction: Cardiotoxicity following thoracic radiotherapy for lung cancer.更正：肺癌胸部放疗后的心脏毒性。
Br J Cancer. 2025 Mar;132(4):401-407. doi: 10.1038/s41416-024-02926-x.
2
Cardiotoxicity following thoracic radiotherapy for lung cancer.肺癌胸部放疗后的心脏毒性
Br J Cancer. 2025 Mar;132(4):311-325. doi: 10.1038/s41416-024-02888-0. Epub 2024 Nov 6.
3
Dosimetric Predictors of Cardiotoxicity in Thoracic Radiotherapy for Lung Cancer.肺癌胸部放疗中心脏毒性的剂量学预测因素。
Clin Lung Cancer. 2019 Nov;20(6):435-441. doi: 10.1016/j.cllc.2019.05.014. Epub 2019 Jun 5.
4
Cardiotoxicity of Anti-Cancer Radiation Therapy: a Focus on Heart Failure.抗癌放射治疗的心脏毒性：聚焦心力衰竭。
Curr Heart Fail Rep. 2023 Feb;20(1):44-55. doi: 10.1007/s11897-023-00587-0. Epub 2023 Jan 24.
5
Radioprotective effects of gliclazide against irradiation-induced cardiotoxicity and lung injury through inhibiting oxidative stress.格列齐特通过抑制氧化应激对辐射诱导的心脏毒性和肺损伤的防护作用。
Med Oncol. 2022 Sep 7;39(12):199. doi: 10.1007/s12032-022-01803-y.
6
Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.多模态评估胸部放疗致癌症患者急性心脏毒性：研究方案。
BMC Cancer. 2021 Oct 18;21(1):1114. doi: 10.1186/s12885-021-08823-3.
7
Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions.胸部放疗的心脏毒性：现有证据与未来方向。
J Thorac Oncol. 2021 Feb;16(2):216-227. doi: 10.1016/j.jtho.2020.11.002. Epub 2020 Dec 3.
8
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis.肺癌大剂量胸部放疗后心脏不良事件的剂量-体积预测因素：一项系统评价和荟萃分析。
BMC Cancer. 2024 Dec 20;24(1):1556. doi: 10.1186/s12885-024-13281-8.
9
Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy.接受胸部放疗和免疫治疗的肺癌患者的心脏毒性
Front Oncol. 2023 Jan 9;12:1025455. doi: 10.3389/fonc.2022.1025455. eCollection 2022.
10
[Normal tissue tolerance to external beam radiation therapy: cardiac structures].[正常组织对外照射放疗的耐受性：心脏结构]
Cancer Radiother. 2010 Jul;14(4-5):319-26. doi: 10.1016/j.canrad.2010.02.006. Epub 2010 May 23.
本文引用的文献
1
Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy.肺癌放疗后心脏亚结构辐射剂量及其与快速性心律失常和缓慢性心律失常的关联
JACC CardioOncol. 2024 Aug 20;6(4):544-556. doi: 10.1016/j.jaccao.2024.07.005. eCollection 2024 Aug.
2
Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer.预测局部晚期非小细胞肺癌放疗后的不良心脏事件
JACC CardioOncol. 2023 Oct 4;5(6):775-787. doi: 10.1016/j.jaccao.2023.08.007. eCollection 2023 Dec.
3
Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis.根治性放疗后非小细胞肺癌患者的肺静脉剂量与心房颤动风险：NI-HEART 分析。
Radiother Oncol. 2024 Mar;192:110085. doi: 10.1016/j.radonc.2024.110085. Epub 2024 Jan 5.
4
The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study.非小细胞肺癌根治性放疗后心脏基底部偶然辐射剂量与总生存和心脏事件的关系：NI-HEART 研究结果。
Clin Oncol (R Coll Radiol). 2024 Feb;36(2):119-127. doi: 10.1016/j.clon.2023.11.029. Epub 2023 Nov 14.
5
Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation.在免疫检查点抑制剂巩固治疗时代，局部晚期非小细胞肺癌患者的心脏辐射剂量与生存预后差相关，但与心脏事件无关。
Radiother Oncol. 2024 Jan;190:110005. doi: 10.1016/j.radonc.2023.110005. Epub 2023 Nov 14.
6
Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy.冠状动脉钙评分对接受根治性放疗的局部晚期非小细胞肺癌患者的总生存是否有影响。
Radiother Oncol. 2023 Aug;185:109719. doi: 10.1016/j.radonc.2023.109719. Epub 2023 May 29.
7
Demystifying the Results of RTOG 0617: Identification of Dose Sensitive Cardiac Subregions Associated With Overall Survival.解析 RTOG 0617 研究结果：确定与总生存相关的剂量敏感心脏亚区。
J Thorac Oncol. 2023 May;18(5):599-607. doi: 10.1016/j.jtho.2023.01.085. Epub 2023 Feb 3.
8
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer.无进展死亡作为描述局部晚期非小细胞肺癌心脏放射效应的一个终点。
Clin Transl Radiat Oncol. 2023 Jan 13;39:100581. doi: 10.1016/j.ctro.2023.100581. eCollection 2023 Mar.
9
Left Anterior Descending Coronary Artery Radiation Dose Association With All-Cause Mortality in NRG Oncology Trial RTOG 0617.NRG肿瘤学试验RTOG 0617中左前降支冠状动脉辐射剂量与全因死亡率的关联
Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1138-1143. doi: 10.1016/j.ijrobp.2022.11.033. Epub 2022 Nov 24.
10
Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer.心脏剂量和心脏合并症会影响肺癌大分割放疗后因心脏原因导致的死亡。
Front Oncol. 2022 Oct 11;12:1007577. doi: 10.3389/fonc.2022.1007577. eCollection 2022.
Zotero 插件